# Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI

> **NCT00735280** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 2505 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** unfractionated heparin

## Key facts

- **NCT ID:** NCT00735280
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-03
- **Final completion:** 2011-03
- **Target enrollment:** 2505 (ACTUAL)
- **Last updated:** 2012-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735280, "Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00735280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*